Network origin in Michael R. Hanley first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Celtaxsys, Inc.
 Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA.
6
| Extinct | Pharmaceuticals: Major | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael R. Hanley via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
Orthobond Corp.
 Orthobond Corp. Chemicals: Major DiversifiedProcess Industries Orthobond Corp. develops chemicals to help facilitate better material surface bonding. It offers a technology based on self-assembled monolayers of phosphonate (SAMP) and osteoconductive self-assembled monolayer of phosphonate surface modification that elicits a biological response on inorganic implants without the use of a biologic. The company was founded by Gregory E. Lutz and Jeffery Schwartz in 2004 and is headquartered in North Brunswick, NJ. | Chemicals: Major Diversified | Director/Board Member | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
| VIRIOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ACCELERATED PHARMA INC | Medical Specialties | Chairman | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Undergraduate Degree | |
The Invus Group LLC
 The Invus Group LLC Investment ManagersFinance The Invus Group LLC is an Independent Venture Capital firm founded in 1985 by Raymond Debbane. The Invus Group LLC is headquartered in New York, US with additional office in Paris. | Investment Managers | Private Equity Investor | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
| Miami University | College/University | Doctorate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree | |
| University of California San Diego | College/University | Undergraduate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal | |
| American University of Beirut | College/University | Undergraduate Degree | |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Investment Managers | Corporate Officer/Principal | |
| The Rockefeller University | College/University | Corporate Officer/Principal | |
Invus Public Equities Advisors LLC
 Invus Public Equities Advisors LLC Investment ManagersFinance Invus Public Equities Advisors LLC is an investment advisory firm headquartered in New York City. The firm was founded by Raymond Debbane in 1985 and is a subsidiary of The Invus Group LLC. Invus Public Equities Advisors serves as the general partner of Invus Public Equities, L.P. | Investment Managers | Portfolio Manager-Equities | |
| Universidad de Buenos Aires | College/University | Doctorate Degree | |
| Universidad Mariano Egaña | College/University | Undergraduate Degree | |
The Olayan Group
 The Olayan Group Investment ManagersFinance The Olayan Group operates as a diversified enterprise that engages in trading, manufacturing, services and investments sectors. It manages commercial and industrial operations in Saudi Arabia through its subsidiary Olayan Financing Company. The firm’s investment team focuses on public and private equities, real estate, fixed income securities, and other specialized assets. It operates through its offices located in Europe, Saudi Arabia and the United States. The company was founded by Suliman S. Olayan in 1947 and is headquartered in Riyadh, Saudi Arabia. | Investment Managers | Corporate Officer/Principal | |
| Children of Armenia Fund | Director/Board Member | ||
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
| SENSORION | Pharmaceuticals: Major | Chairman | |
| INHIBIKASE THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder | |
| Drug Innovation Ventures At Emory LLC | Chief Tech/Sci/R&D Officer | ||
Emory Institute For Drug Development
 Emory Institute For Drug Development Miscellaneous Commercial ServicesCommercial Services Emory Institute For Drug Development engages in drug discovery and development in industry and academia. It provides organization, facilities and resources to translate academic drug discovery into clinical candidates. The company was founded by Dennis C. Liotta in 2009 and is headquartered in Atlanta, GA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| PROTAGENIC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Solving Kids Cancer | Director/Board Member | ||
Antios Therapeutics, Inc.
 Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Founder | |
ElevateBio LLC
 ElevateBio LLC BiotechnologyHealth Technology ElevateBio LLC is a biotechnology holding company, which creates and operates a broad portfolio of cell and gene therapy companies. It builds single and multi-product companies by providing scientific founders with bench-to-bedside capabilities including scientists, manufacturing facilities, drug developers, and commercial expertise. The company was founded by David L. Hallal, Vikas Sinha, and Mitchell H. Finer and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Naia Rare Diseases LLC
 Naia Rare Diseases LLC Medical/Nursing ServicesHealth Services Naia Rare Diseases, Inc. develops pharmaceutical drugs for Short Bowel Syndrome (SBS) and other rare gastrointestinal diseases. The firm offers NB 1001 for adult SBS, NB 1001 for pediatric SBS, and NB 1002, a GLP-2 agonist. The company was founded by H. Daniel Perez and Mark Bagnall in 2014 and is headquartered in Cayman Islands. | Medical/Nursing Services | Chief Executive Officer | |
| Winship Cancer Institute | Corporate Officer/Principal | ||
Life Generation Ltd.
 Life Generation Ltd. Miscellaneous Commercial ServicesCommercial Services Life Generation Ltd. provides technical and vocational secondary education services. The private company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member |
Statistics
International
| United States | 29 |
| France | 3 |
| United Kingdom | 3 |
| Lebanon | 2 |
| Argentina | 2 |
Sectoral
| Health Technology | 14 |
| Consumer Services | 10 |
| Finance | 5 |
| Commercial Services | 4 |
| Process Industries | 2 |
Operational
| Director/Board Member | 19 |
| Chief Tech/Sci/R&D Officer | 6 |
| Independent Dir/Board Member | 5 |
| Corporate Officer/Principal | 5 |
| Chief Executive Officer | 5 |
Most connected contacts
| Insiders | |
|---|---|
| Khalil Barrage | 15 |
| H. Perez | 11 |
| Abel de la Rosa | 8 |
| Milton Werner | 6 |
| Brett A. Premack | 1 |
| Edward E. Philpot | 1 |
- Stock Market
- Insiders
- Michael R. Hanley
- Company connections
